IPGP

Over the past six months, IPG Photonics' stock experienced several notable events. On February 12, 2026, the stock saw its largest daily move, increasing by +35.5% at market close, coinciding with the announcement of strong fourth-quarter 2025 financial results that exceeded expectations and positive Q1 2026 guidance. On May 5, 2026, the stock declined by -25.74% following the announcement of its first-quarter 2026 financial results and a global settlement of patent litigation with TRUMPF, with gross margin decreasing due to tariffs and higher product costs despite a 17% year-over-year revenue increase. On July 16, 2026, the stock increased by +0.94% after announcing a binding offer to acquire Lumibird Medical. On August 4, 2026, the stock rose by +7.88% after IPG Photonics announced its second-quarter 2026 financial results, reporting revenue and adjusted earnings per share that exceeded analyst expectations, along with a book-to-bill ratio above 1.0 for the third consecutive quarter. News emerged on September 8, 2026, of IPG Photonics' plans for a €300M-plus deal for Lumibird Medical. The stock experienced a -6.36% change on September 14, 2026, and its 1-year change from September 18, 2025, to September 18, 2026, was -7.4%.